Cibc World Market Inc. Boosts Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Cibc World Market Inc. lifted its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 2.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 360,018 shares of the company's stock after purchasing an additional 9,954 shares during the period. Cibc World Market Inc. owned about 0.29% of Henry Schein worth $24,913,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in HSIC. ING Groep NV acquired a new stake in Henry Schein during the 3rd quarter valued at approximately $63,226,000. Holocene Advisors LP bought a new position in Henry Schein during the third quarter worth $58,319,000. Healthcare of Ontario Pension Plan Trust Fund acquired a new position in Henry Schein in the third quarter valued at $43,740,000. Southpoint Capital Advisors LP boosted its position in Henry Schein by 30.0% during the third quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company's stock valued at $189,540,000 after acquiring an additional 600,000 shares during the last quarter. Finally, Bank of Montreal Can grew its holdings in Henry Schein by 365.6% during the 3rd quarter. Bank of Montreal Can now owns 711,487 shares of the company's stock worth $52,095,000 after acquiring an additional 558,689 shares during the period. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Stock Performance

Shares of NASDAQ HSIC traded up $0.72 during mid-day trading on Tuesday, hitting $80.29. The company had a trading volume of 556,519 shares, compared to its average volume of 1,409,457. The stock's 50-day moving average price is $73.47 and its 200-day moving average price is $71.52. The company has a market capitalization of $10.01 billion, a price-to-earnings ratio of 33.05, a P/E/G ratio of 2.21 and a beta of 0.91. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 1 year low of $63.67 and a 1 year high of $82.63.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, topping analysts' consensus estimates of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same quarter in the prior year, the firm posted $1.32 EPS. Henry Schein's revenue was up .4% on a year-over-year basis. On average, sell-side analysts forecast that Henry Schein, Inc. will post 4.76 earnings per share for the current year.

Analyst Ratings Changes

HSIC has been the topic of several research analyst reports. Bank of America upgraded Henry Schein from an "underperform" rating to a "buy" rating and upped their target price for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Jefferies Financial Group raised their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research report on Thursday, January 23rd. Mizuho assumed coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a "neutral" rating and a $75.00 target price on the stock. StockNews.com upgraded shares of Henry Schein from a "sell" rating to a "hold" rating in a report on Thursday, November 7th. Finally, Evercore ISI increased their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the stock an "in-line" rating in a research report on Tuesday, October 8th. Seven investment analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Henry Schein presently has a consensus rating of "Moderate Buy" and an average price target of $80.10.

Insider Transactions at Henry Schein

In related news, COO Michael S. Ettinger sold 12,240 shares of the firm's stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the sale, the chief operating officer now directly owns 87,706 shares of the company's stock, valued at $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 1.14% of the company's stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.